Supply and Demand To Boost 3 Water ETFs

Supply and demand forces are dictating that the global water sector is expected to witness growth and positive price support in the future, making the PowerShares Water Resources (PHO), the PowerShares Global Water (PIO) and the Guggenheim S&P Global Water (CGW) attractive investments.

According to the World Resources Institute, consumption of water has been growing at a rate more than twice that of population growth.  Demand for the essential commodity is expected to increase by more than 50 percent over the next 15 years in developing markets and by more than 15 percent in developed markets like the United States. 

Asia Could Boost Solar ETFs

Nearly five months ago, the Asian Development Bank started a major drive to promote the use of solar power throughout the continent which could eventually lead to positive price support in the Guggenheim Solar ETF (TAN) and the Market Vectors Solar Energy ETF (KWT).

Under this initiative, the Asian Development Bank aims to put in place solar power projects with a total capacity of 3,000 megawatts by 2013, pushing capacity to six times what it currently is.  The solar move is especially taking place in India, where the government has committed $20 billion to its solar program in hopes of having 20,000 megawatts of grid-connected solar energy by 2022 and nearly 200 megawatts of off-grid solar energy by 2013. 

ETF Based On Islam To Shut Doors

On October 19, 2010, Javelin Exchange Traded Shares will officially close the door on the Dow Jones Islamic Market International Index Fund (JVS). 

JVS first began trading in July 2009 and came to market to offer investors a way to gain access to companies that abided by Islamic law.  The strategy excluded businesses that were involved in the alcohol and tobacco industries, gambling, pornography, unconventional financial services and those that produced pork-related food products.  Some of JVS’ holdings include metals and mining giant BHP Billiton (BHP), pharmaceutical giants Novartis (NVS) and GlaxoSmithKline (GSK) as well as energy giant BP (BP).